@emailpete, I would say most of Warrant already converted to mother shares and now only left 177m Warrant as per Annual Report mentioned as of 12 Aug 21 which is about 35% dilution only.
The slight dilution is more than enough off set by upcoming new plant A production expansion at Chemor, Perak. It should be completed Construction in July 2021 ad gotta further check with management during coming GM. With Immediate New Plant Production Contribution in next 2 quarters, the earning should be marvelous.
The potential risk is ASP of Hand Former as management did mention the spot order is few times higher than log term contract which we don't know its Sales Mixed Ratio and Spot ASP info.
A minor correction to the 4 Quarter EPS I quoted yesterday. I added the previous quarters from quarterly EPS figures quoted on a financial website, which totalled 7.07 cents.
The actual EPS quoted by the company in their annual report is 6.68 cents. A minor difference but I like to be accurate.
For the record,Undiluted EPS is currently 6.68 cents. Diluted EPS is 4.67 cents.
Many are ignorant that esceramic price movement is not related to gloves stocks. Esceram is manufacturing hand formers as their main product line. And of course, the price movement follow the gloves stocks. Just saying.
Sugan21, as I've mentioned a few times in the last couple of months, 46 was a very important support level and I suggested shareholders wouldn't want the price to break down below that level. Unfortunately for holders, it has.
Next level of important support is 40 cents, as important as 46 cents was.
Best of luck to holders as this MIGHT get a bit tricky.
Esceramic is a good fundamental company. Even with their recent GM - it mentioned sales are majority coming from China. As China is expanding their huge market there.
The thing I don’t get it - why the sell down of esceramic when they are not even gloves counter?
Their hand former products are not much competition and in the report also mentioned ASP has been gradually increasing.
To say that Esceram is not a glove counter is obviously correct, however if anyone suggests that it is not "bolted on" to the industry is misguided. Without glove companies, Esceram doesn't have a business. It's a bit like saying Coca Cola is not part of the beverage industry.
By default, being linked to the glove industry will effect their valuations, in particular what PE the market participants are willing to ascribe to the company.
Currently, the major glove companies are trading on a PE between 2 and 4. Supermax is now trading on a PE of less than 2 and this company has delivered profits over the last 3 quarters of an average of Rm1 Billion each quarter! In very simple terms, the market can't work out what these companies will deliver in SUSTAINED profits over the next 2 or 3 years.
With those facts in mind, what PE would you be willing to give to Esceram? I don't have the answer but in this current situation I would not be willing to give it a PE of over 5.
The price is currently 40.5, with a technical Fibonacci support at 40 cents. If it breaks below 40 cents then the next Fibonacci support is 33.5 cents.
Purely coincidently, as Esceram has a current EPS of 6.68 cents, if you were to give it a PE of 5 this gives a price of 33.4 cents. Exactly the same price as the current 33.5 cents Fib. support.
Don't read too much into that as it is purely a coincidence.
Just my thoughts, some may agree and I'm sure many others will disagree :)
Thanks TreeTopView. I will keep this as the price to trigger my averaging purchase.
The price is currently 40.5, with a technical Fibonacci support at 40 cents. If it breaks below 40 cents then the next Fibonacci support is 33.5 cents.
Purely coincidently, as Esceram has a current EPS of 6.68 cents, if you were to give it a PE of 5 this gives a price of 33.4 cents. Exactly the same price as the current 33.5 cents Fib. support.
Don't read too much into that as it is purely a coincidence.
Just my thoughts, some may agree and I'm sure many others will disagree :) 15/09/2021 1:12 PM
@smyang11 Do you know what is a correction? Let me help.
What Is a Correction? In investing, a correction is a decline in the price of a security from its most recent peak. Corrections can happen to individual assets, like an individual stock or bond, or to an index measuring a group of assets.
An asset, index, or market may fall into a correction either briefly or for sustained periods—days, weeks, months, or even longer. However, the average market correction is short-lived and lasts anywhere between three and four months.
It is interesting to note that you appear to have joined the i3 forum yesterday and seem to be very enthusiastic to promote Esceram. So much so, that you have even posted your initial promotional piece on Esceram on 6 other forum threads.
Is there a reason for that? Or perhaps you want to share the love :)
Being the cynic that I am, I'll assume you have numerous names you use in i3 to do your dirty work.
I find the input from FacstN0tFiction quite sound and logical. Without expansion already capable of MYR 15 m/quarter. Excellent fundamentals. Would anybody be able to inform what would be the NOSH if all the outstanding warrants are converted? Maybe this would be a good way to estimate the value of the share based on our own expectation of earnings. I have my own estimate at 60 m on a non EMCO full year. That I think would be 2023. 2022 ending may 31st 2022, close eyes above 40 m because expansion not completed and EMCO curtailed Q1. So, here you go as I am a shareholder since 2008 and collecting along the way. Thanks to all for inputs as worse case scenario, I will enjoy the dividends whilst waiting for share appreciation. I have no agenda here, just giving a balanced view.
Good morning @shrewdinvestor, I hope you are having a wonderful Malaysia Day and are able to spend some quality time with your family.
As you are a long term shareholder I was a little bit surprised that you thought "the input from FacstN0tFiction quite sound and logical". Apart from his promotional bias he actually came up with only two factual points that were debatable:
1. The Company has Rm75 Million cash......Correct. 2. The Company has no debt......False.
So, a 50% strike rate, not something I'd be willing to give the praise of "the input from FacstN0tFiction quite sound and logical".
As for your question of how many shares in the Company once fully diluted, 645,986,624 shares (Ref: Annual Report).
I'm not sure if you have read the recent Annual Report, if you haven't then I'd suggest it is worth spending a bit of time on. They appear, in their own words, to be far more cautious of future revenue than you do, citing growing market competition and material costs. That could be something to consider in looking to forward projections.
As I have said numerous times here, I'm not a holder of Esceram shares and my interest was only initially a technical charting exercise for me. I seem to have been sucked in to some fundamental analysis that was never intended. I think I'll leave any further comments on the company's fundamentals to those who hold shares and may have more insightful contributions.
Good afternoon, thank you for the information. I am currently reading the AR21, just downloaded. I believe that they are going on an automation journey for production. I am optimistic for them as I am an industry person for over 30 years and running an industrial business in Asian market. This company is a winner but again, I am not Warren Buffet! It's just that you don't have too many companies as sound and uncomplicated as this. The USP is clear to see and barriers to entry are high. Anyway, good discussions. Thank you
@TreeTopView I actually agree with FactsN0tFiction. He's just stating the facts and numbers.
TreeTopView, you spend a lot of time on the Esceram page and yet you do not know a thing about the company. You said that the company having no debt is false but you are afraid to post the amount of debt. You want to paint an image of Esceram as if it has half the debt of it's cash. Esceram has only RM250k in debt. Isn't saying that is has NO DEBT because it has RM75 million cash VS RM250k debt, justifiable? Yet, you are afraid to post it. You act as if you are for the truth and numbers. Which company don't have competition? You say you read annual reports, but only hand pick a few sentences here and there. In the report, it also says,
"The Group has further undertaken steps to upgrade its operational capabilities through investments in viable technology or processes to improve productivity and efficiency. This will help the Group continue to enhance its growth trajectory"
Like I said, why are you so afraid to post the real debt of Esceram? Esceram has literally no debt with RM75 million cash vs RM250k debt. Don't be afraid to do more research next time TreeTopView.
lndependentlnvestor, you are clearly hot under the collar at my post.
You state that I'm "so afraid to post the real debt". Are you serious??
ALL shareholders should know the REAL debt the company has, as it is CRYSTAL CLEAR in the Annual Report! So if I know, WHY don't you?
Stated very clearly in their AR, that the co0mpany have taken a RM14.5 Million bank facility that they will draw down from subsequent from the time of the AR.
NOT Rm250k, as you state.
I will accept an apology if you are man enough to offer it.
Post a Comment
People who like this
New Topic
You should check in on some of those fields below.
Title
Category
Comment
Confirmation
Click Confirm to delete this Forum Thread and all the associated comments.
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....
clc689
42 posts
Posted by clc689 > 2021-09-11 01:09 | Report Abuse
@emailpete, I would say most of Warrant already converted to mother shares and now only left 177m Warrant as per Annual Report mentioned as of 12 Aug 21 which is about 35% dilution only.
The slight dilution is more than enough off set by upcoming new plant A production expansion at Chemor, Perak.
It should be completed Construction in July 2021 ad gotta further check with management during coming GM. With Immediate New Plant Production Contribution in next 2 quarters, the earning should be marvelous.
The potential risk is ASP of Hand Former as management did mention the spot order is few times higher than log term contract which we don't know its Sales Mixed Ratio and Spot ASP info.